Literature DB >> 7919638

Age-related changes in the gastrointestinal system. Effects on drug therapy.

F L Iber1, P A Murphy, E S Connor.   

Abstract

Although there are many changes in the gastrointestinal tract with aging, only those in the liver substantially influence blood concentrations and clearance of drugs. The liver mass, overall function, and blood flow decrease approximately 1% per year after age 40 to 50 years, and accordingly, the hepatic metabolism or clearance of drugs decreases in this proportion. The sensitivity of the gastrointestinal tract to usual concentrations of drugs is increased, and this, in part, accounts for the increased frequency of adverse drug reactions in elderly patients.

Entities:  

Mesh:

Year:  1994        PMID: 7919638     DOI: 10.2165/00002512-199405010-00004

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  123 in total

1.  Autonomic dysfunction in men with Parkinson's disease.

Authors:  C Singer; W J Weiner; J R Sanchez-Ramos
Journal:  Eur Neurol       Date:  1992       Impact factor: 1.710

2.  The effect of age on glucuronidation and sulphation of paracetamol by human liver fractions.

Authors:  B Herd; H Wynne; P Wright; O James; K Woodhouse
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

Review 3.  Drug-nutrient interactions.

Authors:  A Trovato; D N Nuhlicek; J E Midtling
Journal:  Am Fam Physician       Date:  1991-11       Impact factor: 3.292

Review 4.  Altered pharmacokinetics in the elderly.

Authors:  G J Yuen
Journal:  Clin Geriatr Med       Date:  1990-05       Impact factor: 3.076

5.  Age-associated stereoselective alterations in hexobarbital metabolism.

Authors:  M H Chandler; S R Scott; R A Blouin
Journal:  Clin Pharmacol Ther       Date:  1988-04       Impact factor: 6.875

6.  Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man.

Authors:  D Pertsemlidis; D Panveliwalla; E H Ahrens
Journal:  Gastroenterology       Date:  1974-04       Impact factor: 22.682

Review 7.  Gene expression and aging.

Authors:  M K Thakur; T Oka; Y Natori
Journal:  Mech Ageing Dev       Date:  1993-01       Impact factor: 5.432

8.  Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance.

Authors:  M Schnegg; B H Lauterburg
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

9.  Comparative endotoxin-induced hepatic injury in young and aged rats.

Authors:  S K Durham; A Brouwer; R J Barelds; M A Horan; D L Knook
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

10.  Interindividual variability in the glucuronidation and sulphation of ethinyloestradiol in human liver.

Authors:  A Temellini; L Giuliani; G M Pacifici
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

View more
  15 in total

Review 1.  Drug dosage in the elderly: dermatological drugs.

Authors:  Anna Flammiger; Howard Maibach
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  Outcome of acute liver failure in the elderly.

Authors:  Frank V Schiødt; Raymond T Chung; Michael L Schilsky; J Eileen Hay; Erik Christensen; William M Lee
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

Review 3.  Use of antidepressants in late-life depression.

Authors:  Tarek K Rajji; Benoit H Mulsant; Francis E Lotrich; Cynthia Lokker; Charles F Reynolds
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

4.  The pharmacokinetics of zileuton in healthy young and elderly volunteers.

Authors:  R A Braeckman; G R Granneman; C S Locke; J M Machinist; J H Cavannaugh; W M Awni
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

5.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

6.  Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.

Authors:  O Kozawa; T Uematsu; H Matsuno; M Niwa; S Nagashima; M Kanamaru
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

Review 7.  Aging and liver disease.

Authors:  In Hee Kim; Tatiana Kisseleva; David A Brenner
Journal:  Curr Opin Gastroenterol       Date:  2015-05       Impact factor: 3.287

Review 8.  Aging of the Liver: What This Means for Patients with HIV.

Authors:  Austin W Chan; Yuval A Patel; Steve Choi
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

Review 9.  Drug therapy and the older person: role of the pharmacist.

Authors:  M J Denham; N L Barnett
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

10.  Actual drug-drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study.

Authors:  Srecko Marusic; Vesna Bacic-Vrca; Paulo Roque Obreli Neto; Miljenko Franic; Viktorija Erdeljic; Nives Gojo-Tomic
Journal:  Eur J Clin Pharmacol       Date:  2013-06-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.